Barinthus Biotherapeutics (BRNS) Stock Chart & Stock Price History $0.96 +0.05 (+5.15%) Closing price 05/5/2025 03:50 PM EasternExtended Trading$0.92 -0.03 (-3.55%) As of 05/5/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Barinthus Biotherapeutics Stock Price Performance 5 Day Performance-12.02%1 Month Performance+40.62%3 Month Performance-3.91%6 Month Performance-35.64%Year-To-Date Performance-20.61%1 Year Performance-56.61% Receive BRNS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address BRNS Stock Chart for Tuesday, May, 6, 2025 BRNS Chart by TradingView Barinthus Biotherapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/05/2025$0.91$0.96+5.15%$1.00$0.8748,652 shs$38.69 million05/02/2025$1.09$0.91-16.33%$1.13$0.8878,292 shs$36.79 million05/01/2025$1.12$1.09-2.68%$1.13$1.0545,970 shs$43.97 million04/30/2025$1.00$1.12+12.01%$1.12$1.0039,864 shs$45.18 million04/29/2025$0.84$1.00+19.18%$1.06$0.81124,958 shs$40.34 million04/28/2025$0.82$0.84+1.94%$0.96$0.76137,407 shs$33.84 million04/25/2025$0.82$0.82+0.86%$0.86$0.7925,645 shs$33.20 million04/24/2025$0.82$0.82+0.01%$0.84$0.7714,648 shs$32.92 million04/23/2025$0.76$0.82+8.07%$0.97$0.7538,578 shs$32.91 million04/22/2025$0.71$0.76+6.34%$0.78$0.723,474 shs$30.46 million Get the Latest News and Ratings for BRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/21/2025$0.73$0.71-2.73%$0.73$0.711,888 shs$28.64 million04/18/2025$0.73$0.73$0.73$0.712,304 shs$29.44 million04/17/2025$0.71$0.73+3.53%$0.73$0.712,304 shs$29.44 million04/16/2025$0.68$0.71+3.52%$0.73$0.687,295 shs$28.44 million04/15/2025$0.70$0.68-2.60%$0.73$0.689,486 shs$27.47 million04/14/2025$0.70$0.70-0.60%$0.73$0.703,916 shs$28.21 million04/11/2025$0.69$0.70+2.69%$0.73$0.6529,814 shs$28.37 million04/10/2025$0.69$0.69-0.25%$0.75$0.6439,628 shs$27.63 million04/09/2025$0.71$0.69-3.69%$0.70$0.6592,107 shs$27.70 million04/09/2025$0.71$0.69-3.69%$0.70$0.6592,107 shs$27.70 million04/08/2025$0.69$0.71+2.74%$0.84$0.6826,063 shs$28.76 million04/08/2025$0.69$0.71+2.74%$0.84$0.6826,063 shs$28.76 million04/07/2025$0.68$0.69+1.76%$0.75$0.689,044 shs$28.00 million Related Companies GLSI Stock Chart FTLF Stock Chart THTX Stock Chart CGEN Stock Chart LYEL Stock Chart EDIT Stock Chart TARA Stock Chart ENTA Stock Chart NMRA Stock Chart RAPT Stock Chart Receive BRNS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BRNS) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Barinthus Biotherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Barinthus Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BRNS Stock Free BRNS Stock Alerts